IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations
IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations
10/01/2026 | Press release | Distributed by Public on 10/01/2026 07:59
78th WHO Regional Committee for the Americas: Plan of action for cervical cancer prevention and control 2018-2030
On 1 October 2026 in Washington, D.C., IFPMA delivered a statement on the plan of action for cervical cancer prevention and control 2018-2030 at the 63rd Directing Council of the Pan American Health Organization and ahead of the 78th WHO Regional Committee for the Americas.
We welcome the progress achieved by PAHO and countries across the region in advancing the Cervical Cancer Elimination Initiative and reaffirm our commitment to the shared goal of eliminating cervical cancer and reducing the burden of HPV-related diseases.
Reaching this goal requires a comprehensive, life-course approach to prevention, including equitable access to and uptake of HPV vaccination for girls and boys, as well as catch-up vaccination for adolescents and young adults. Continued investment in HPV vaccination, screening, and early detection programs is critical to sustaining momentum and expanding access to prevention and care.
We further recognize that significant progress depends on strong partnerships among governments, PAHO, civil society, healthcare professionals, and industry. Through continued collaboration and commitment, we can strengthen prevention efforts, improve access to innovative and effective interventions, and accelerate progress toward a future free from HPV-related cancers.
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Media Contact
Elliot Dunster [email protected]
IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on October 01, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 01, 2026 at 13:59 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]